MMCM
MEDP icon

Murphy & Mullick Capital Management’s Medpace MEDP Stock Holding History

Murphy & Mullick Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7K Hold
22
– – 0.01% 475
2026
Q1 		$10.6K Hold
22
– – 0.01% 466
2025
Q4 		$12.4K Hold
22
– – 0.01% 455
2025
Q3 		$11.3K Hold
22
– – 0.01% 452
2025
Q2 		$9.4K Hold
22
– – 0.01% 468
2025
Q1 		$6.7K Hold
22
– – 0.01% 482
2024
Q4 		$7.31K Buy
+22
New +$7.46K 0.01% 471

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Murphy & Mullick Capital Management's MEDP Position: Q2 2026 in Review

Murphy & Mullick Capital Management held its Medpace (MEDP) position steady in Q2 2026 at 22 shares worth $11.7K. The position accounts for 0.01% of the portfolio, ranked #475.

Murphy & Mullick Capital Management first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.4K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Murphy & Mullick Capital Management held 22 shares of Medpace worth $11.7K as of Q2 2026.
  • Murphy & Mullick Capital Management left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #475 holding.
  • Murphy & Mullick Capital Management first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Murphy & Mullick Capital Management's Medpace position peaked at $12.4K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.